595
Views
20
CrossRef citations to date
0
Altmetric
REVIEWS

Tertiary Lymphoid Tissue in the Tumor Microenvironment: From Its Occurrence to Immunotherapeutic Implications

, , , , , , & show all
Pages 123-133 | Accepted 09 Feb 2015, Published online: 22 Apr 2015

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (1)

Giovanni Francesco Castino, Nina Cortese, Giovanni Capretti, Simone Serio, Giuseppe Di Caro, Rossana Mineri, Elena Magrini, Fabio Grizzi, Paola Cappello, Francesco Novelli, Paola Spaggiari, Massimo Roncalli, Cristina Ridolfi, Francesca Gavazzi, Alessandro Zerbi, Paola Allavena & Federica Marchesi. (2016) Spatial distribution of B cells predicts prognosis in human pancreatic adenocarcinoma. OncoImmunology 5:4.
Read now

Articles from other publishers (19)

Qianqian Zhang & Suhui Wu. (2023) Tertiary lymphoid structures are critical for cancer prognosis and therapeutic response. Frontiers in Immunology 13.
Crossref
Yan Lin, De-Xia Kong & You-Ni Zhang. (2022) Does the Microbiota Composition Influence the Efficacy of Colorectal Cancer Immunotherapy?. Frontiers in Oncology 12.
Crossref
Ilaria Grazia Zizzari, Alessandra Di Filippo, Andrea Botticelli, Lidia Strigari, Angelina Pernazza, Emma Rullo, Maria Gemma Pignataro, Alessio Ugolini, Fabio Scirocchi, Francesca Romana Di Pietro, Ernesto Rossi, Alain Gelibter, Giovanni Schinzari, Giulia D'Amati, Aurelia Rughetti, Paolo Marchetti, Marianna Nuti & Chiara Napoletano. (2022) Circulating CD137+ T Cells Correlate with Improved Response to Anti-PD1 Immunotherapy in Patients with Cancer. Clinical Cancer Research 28:5, pages 1027-1037.
Crossref
Marie Muller, Vincent Haghnejad, Marion Schaefer, Guillaume Gauchotte, Bénédicte Caron, Laurent Peyrin-Biroulet, Jean-Pierre Bronowicki, Cindy Neuzillet & Anthony Lopez. (2022) The Immune Landscape of Human Pancreatic Ductal Carcinoma: Key Players, Clinical Implications, and Challenges. Cancers 14:4, pages 995.
Crossref
Meng Qin, Ying Jin & Ling-Ya Pan. (2021) Tertiary lymphoid structure and B‑cell‑related pathways: A potential target in tumor immunotherapy (Review). Oncology Letters 22:6.
Crossref
Jennifer L Vella, Aleksey Molodtsov, Christina V Angeles, Bruce R Branchini, Mary Jo Turk & Yina H Huang. (2021) Dendritic cells maintain anti-tumor immunity by positioning CD8 skin-resident memory T cells. Life Science Alliance 4:10, pages e202101056.
Crossref
Wendi Kang, Zhichao Feng, Jianwei Luo, Zhenhu He, Jun Liu, Jianzhen Wu & Pengfei Rong. (2021) Tertiary Lymphoid Structures in Cancer: The Double-Edged Sword Role in Antitumor Immunity and Potential Therapeutic Induction Strategies. Frontiers in Immunology 12.
Crossref
Qunxing Li, Xiangqi Liu, Dikan Wang, Yanqiong Wang, Huanzi Lu, Shuqiong Wen, Juan Fang, Bin Cheng & Zhi Wang. (2020) Prognostic value of tertiary lymphoid structure and tumour infiltrating lymphocytes in oral squamous cell carcinoma. International Journal of Oral Science 12:1.
Crossref
Daniela Bruni, Helen K. Angell & Jérôme Galon. (2020) The immune contexture and Immunoscore in cancer prognosis and therapeutic efficacy. Nature Reviews Cancer 20:11, pages 662-680.
Crossref
Dongmei Ai, Gang Liu, Xiaoxin Li, Yuduo Wang & Man Guo. (2020) Calculation of immune cell proportion from batch tumor gene expression profile based on support vector regression. Journal of Bioinformatics and Computational Biology 18:05, pages 2050030.
Crossref
Xiaoting Pan, Heyun Tao, Mengjun Nie, Yuanjie Liu, Pan Huang, Shenlin Liu, Wei Sun, Jian Wu, Ting Ma, Anwei Dai, Jianwei Lu, Baorui Liu, Xi Zou & Qingmin Sun. (2020) A clinical study of traditional Chinese medicine prolonging the survival of advanced gastric cancer patients by regulating the immunosuppressive cell population. Medicine 99:16, pages e19757.
Crossref
Pascal Jézéquel, Olivier Kerdraon, Hubert Hondermarck, Catherine Guérin-Charbonnel, Hamza Lasla, Wilfried Gouraud, Jean-Luc Canon, Andrea Gombos, Florence Dalenc, Suzette Delaloge, Jérôme Lemonnier, Delphine Loussouarn, Véronique Verrièle & Mario Campone. (2019) Identification of three subtypes of triple-negative breast cancer with potential therapeutic implications. Breast Cancer Research 21:1.
Crossref
Eun Kyung Kim, Yoon Ah Cho, Mi-kyoung Seo, Hyunmi Ryu, Byoung Chul Cho, Yoon Woo Koh & Sun Och Yoon. (2019) NOVA1 induction by inflammation and NOVA1 suppression by epigenetic regulation in head and neck squamous cell carcinoma. Scientific Reports 9:1.
Crossref
Liangbin Lin, Xiang Hu, Huiyuan Zhang & Hongbo Hu. (2019) Tertiary Lymphoid Organs in Cancer Immunology: Mechanisms and the New Strategy for Immunotherapy. Frontiers in Immunology 10.
Crossref
Jakob Nikolas Kather & Niels Halama. (2019) Harnessing the innate immune system and local immunological microenvironment to treat colorectal cancer. British Journal of Cancer 120:9, pages 871-882.
Crossref
Marcella Tazzari, Silvia Brich, Alessandra Tuccitto, Fabio Bozzi, Valeria Beretta, Rosalin D. Spagnuolo, Tiziana Negri, Silvia Stacchiotti, Marcello Deraco, Dario Baratti, Chiara Camisaschi, Antonello Villa, Barbara Vergani, Licia Rivoltini, Silvana Pilotti & Chiara Castelli. (2018) Complex Immune Contextures Characterise Malignant Peritoneal Mesothelioma: Loss of Adaptive Immunological Signature in the More Aggressive Histological Types. Journal of Immunology Research 2018, pages 1-13.
Crossref
Wolf H. Fridman, Laurence Zitvogel, Catherine Sautès–Fridman & Guido Kroemer. (2017) The immune contexture in cancer prognosis and treatment. Nature Reviews Clinical Oncology 14:12, pages 717-734.
Crossref
Eun Kyung Kim, Sun Och Yoon, Woon Yong Jung, Hyunjoo Lee, Youngran Kang, You-Jin Jang, Soon Won Hong, Seung Ho Choi & Woo Ick Yang. (2016) Implications of NOVA1 suppression within the microenvironment of gastric cancer: association with immune cell dysregulation. Gastric Cancer 20:3, pages 438-447.
Crossref
Sun Och Yoon, Eun Kyung Kim, Mira Lee, Woon Yong Jung, Hyunjoo Lee, Youngran Kang, You-Jin Jang, Soon Won Hong, Seung Ho Choi & Woo Ick Yang. (2015) NOVA1 inhibition by miR-146b-5p in the remnant tissue microenvironment defines occult residual disease after gastric cancer removal . Oncotarget 7:3, pages 2475-2495.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.